Aarti Drugs Ltd (NSE: AARTIDRUGS) has been trading within a well-defined parallel channel on the monthly timeframe since 2009. The stock is currently at the bottom of the channel, having successfully retested the channel support. This retest could signify a potential bounce, presenting a long-term buying opportunity.
The RSI is also on an upward trajectory.
Sharing this analysis for Long-Term investors.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research before making any investment decisions.
The RSI is also on an upward trajectory.
Sharing this analysis for Long-Term investors.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research before making any investment decisions.